A guide to further medical use inventions at the EPO
Ylva Skoglösa and Camilla Lidén of Valea discuss the role and meaning of novelty in further medical use applications in Europe
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: